scispace - formally typeset
G

Garret A. FitzGerald

Researcher at University of Pennsylvania

Publications -  573
Citations -  64984

Garret A. FitzGerald is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Prostacyclin & Thromboxane. The author has an hindex of 127, co-authored 547 publications receiving 60448 citations. Previous affiliations of Garret A. FitzGerald include French Institute of Health and Medical Research & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension.

TL;DR: In this paper, a non-invasive approach, measurement of the urinary metabolite 2,3-dinor-6-keto-prostaglandin F1 alpha was used to determine prostacyclin biosynthesis in pregnant subjects at risk of developing pregnancy-induced hypertension.
Journal ArticleDOI

Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α

TL;DR: A major component of 8-epi PGF2α formed in serum by healthy volunteers was shown to be sensitive to inhibition by aspirin ex vivo, and may be formed as a PG by human platelets.
Journal ArticleDOI

Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation

TL;DR: Although COX-2 predominates, both COX isozymes are induced and contribute to the prostaglandin response to LPS in humans, and COX activation contributes undetectably to lipid peroxidation induced by LPS.
Journal ArticleDOI

Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival

TL;DR: It is shown that the developmental timing of Bmal1 expression influences the circadian clock’s effects on aging and survival, and the systemic role of the molecular clock in the biology of aging requires reinvestigation in order to increase the likelihood of translation for preclinical studies of the aging process.